NM_015512.5:c.7848C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_015512.5(DNAH1):c.7848C>T(p.Tyr2616Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00361 in 1,613,994 control chromosomes in the GnomAD database, including 174 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.018 ( 74 hom., cov: 33)
Exomes 𝑓: 0.0021 ( 100 hom. )
Consequence
DNAH1
NM_015512.5 synonymous
NM_015512.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.40
Publications
2 publications found
Genes affected
DNAH1 (HGNC:2940): (dynein axonemal heavy chain 1) This gene encodes an inner dynein arm heavy chain that provides structural support between the radial spokes and the outer doublet of the sperm tail. Naturally occurring mutations in this gene are associated with primary ciliary dyskinesia and multiple morphological anomalies of the flagella that result in asthenozoospermia and male infertility. Mice with a homozygous knockout of the orthologous gene are viable but have reduced sperm motility and are infertile. [provided by RefSeq, Feb 2017]
DNAH1 Gene-Disease associations (from GenCC):
- spermatogenic failure 18Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- ciliary dyskinesia, primary, 37Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- non-syndromic male infertility due to sperm motility disorderInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 3-52382362-C-T is Benign according to our data. Variant chr3-52382362-C-T is described in ClinVar as Benign. ClinVar VariationId is 478495.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.39 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0613 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAH1 | NM_015512.5 | c.7848C>T | p.Tyr2616Tyr | synonymous_variant | Exon 50 of 78 | ENST00000420323.7 | NP_056327.4 | |
| DNAH1 | XM_017006129.2 | c.7917C>T | p.Tyr2639Tyr | synonymous_variant | Exon 52 of 80 | XP_016861618.1 | ||
| DNAH1 | XM_017006130.2 | c.7848C>T | p.Tyr2616Tyr | synonymous_variant | Exon 51 of 79 | XP_016861619.1 | ||
| DNAH1 | XM_017006131.2 | c.7917C>T | p.Tyr2639Tyr | synonymous_variant | Exon 52 of 79 | XP_016861620.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0184 AC: 2801AN: 152184Hom.: 74 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2801
AN:
152184
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00485 AC: 1210AN: 249244 AF XY: 0.00399 show subpopulations
GnomAD2 exomes
AF:
AC:
1210
AN:
249244
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00207 AC: 3026AN: 1461692Hom.: 100 Cov.: 32 AF XY: 0.00181 AC XY: 1316AN XY: 727134 show subpopulations
GnomAD4 exome
AF:
AC:
3026
AN:
1461692
Hom.:
Cov.:
32
AF XY:
AC XY:
1316
AN XY:
727134
show subpopulations
African (AFR)
AF:
AC:
2354
AN:
33480
American (AMR)
AF:
AC:
164
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26132
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
10
AN:
86258
European-Finnish (FIN)
AF:
AC:
21
AN:
53398
Middle Eastern (MID)
AF:
AC:
12
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
199
AN:
1111864
Other (OTH)
AF:
AC:
266
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
179
359
538
718
897
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0184 AC: 2805AN: 152302Hom.: 74 Cov.: 33 AF XY: 0.0180 AC XY: 1338AN XY: 74474 show subpopulations
GnomAD4 genome
AF:
AC:
2805
AN:
152302
Hom.:
Cov.:
33
AF XY:
AC XY:
1338
AN XY:
74474
show subpopulations
African (AFR)
AF:
AC:
2632
AN:
41550
American (AMR)
AF:
AC:
130
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
AC:
1
AN:
10618
Middle Eastern (MID)
AF:
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17
AN:
68028
Other (OTH)
AF:
AC:
21
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
129
258
388
517
646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Oct 16, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.